Proven Results

Delivering lasting change in oncology, improved partner performance and better patient outcomes.

Tangible Value

Patient Satisfaction (NPS)

28

Patients are likely to recommend our platform. At 28, we’re showing a strong and above average* healthcare NPS score. 

Reduced Resolution Times

30%

Clinics using our platform respond more quickly to patient issues and regularly see a 30%+ improvement in incident resolution times.

Reductions in ED Visits  and Hospitalizations

8%

Reduced unnecessary ED visits and hospitalizations by 8% through improvements in remote symptom management. 

Increased Medication Adherence

16%

Clinics & life sciences partners have seen a 16% increase in time on therapy through timely & proactive digital interventions and patient education.

Texas Oncology Implemented Health Tracker to initiate proactive symptom management to improve outcomes.

“The data shows that digital healthcare systems like Health Tracker can help clinicians manage their patients’ symptoms quickly and efficiently, potentially leading to improved clinical outcomes, fewer visits to emergency departments, higher patient satisfaction, and compliance with therapy,”
– Debra Patt, M.D., Ph.D., MBA
73 %
Adoption Rate
60 %
Resolution in < 1 hour
8 %
Hospital ED Avoidance

Optimizing Care Interventions

Identifying ways to improve digital access among minority communities

Genentech and Navigating Cancer researchers analyzed data from more than 200K people living with cancer, found that most communities of color have limited access and online communication with oncologists on digital health platforms.

A collaboration with Texas Oncology to realize the benefits of ePROs: Dancing the Texas Two-Step through a global pandemic.

In a study of real-world ePRO implementation, Texas Oncology targeted cancer patients initiating systemic therapy to enroll in the Health Tracker ePRO digital monitoring program. The process included patient screening, introduction to the program, enrollment, initiation, observation, and intervention through the triage board workflow. There was a 65% ePRO compliance rate in the 4375 patients enrolled, as well as high participation rates among patients 65 years and older, those completing ePROs via text message, and patients on oral treatment.

Surfacing Disparities in care management to improve outcomes for all patients.

Duke and Navigating Cancer researchers aimed to describe sociodemographic correlates of patient-reported pain among H&N cancer patients receiving care in the community setting. The study found one-in-six HNC patients in the community oncology setting reported pain, and while there were no racial differences in any pain report, white patients were significantly more likely to receive new pain prescriptions, as were those with Medicare or commercial insurance.

Newly diagnosed patients remain on therapy longer when educated.

Navigating Cancer and IQVIA, an industry-leading data partner, collaborated to measure the efficacy of digital patient education through the Navigating Cancer platform.
16 %
Increased Time on Therapy